Patent details

Basic Information

Publication number:

EP3047040

PCT Application Number:

SG2014000446

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP148504418

PCT Publication Number:

WO2015050500

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MULTIGENE ASSAY FOR PROGNOSIS OF RENAL CANCER

French Title of Invention:

DOSAGE MULTIGÉNIQUE POUR LE PRONOSTIC DU CANCER DU REIN

German Title of Invention:

MULTIGENTEST ZUR PROGNOSE VON NIERENKREBS

SPC Number:

Dates

Filing date:

17/09/2014

Grant date:

11/12/2019

EP Publication Date:

27/07/2016

PCT Publication Date:

09/04/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/12/2019

EP B1 Publication Date:

11/12/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/09/2020

Expiration date:

17/09/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/12/2019

 

 

Name:

Lucence Life Sciences Pte Ltd.

Address:

Blk 211 Henderson Road 04/01-02 Henderson Industrial Park, Singapore 159552, Singapore (SG)

Inventor

1

Name:

TAN, Min-Han

Address:

Singapore (SG)

2

Name:

TAN, Puay Hoon

Address:

Singapore (SG)

3

Name:

CHOUDHURY, Yukti

Address:

Singapore (SG)

4

Name:

TEH, Bin Tean

Address:

Singapore (SG)

Priority

Priority Number:

2013070149

Priority Date:

17/09/2013

Priority Country:

Singapore (SG)

Classification

IPC classification:

C12Q 1/6886;

Publication

European Patent Bulletin

Issue number:

201950

Publication date:

11/12/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages